Role of urinary transforming growth factor-beta1 concentration in the diagnosis of upper urinary tract obstruction in

M T El-Sherbiny1, O M Mousa, A A Shokeir

  • 1The Urology and Nephrology Center, Mansoura University, Mansoura, Eygpt.

The Journal of Urology
|September 28, 2002
PubMed

Insights

Transforming growth factor-beta1 (TGF-beta1) in urine aids in diagnosing pediatric kidney obstruction. While levels decrease post-surgery, further study is needed to confirm this trend for TGF-beta1 in obstruction management.

Area of Science:

  • Pediatric Nephrology
  • Urology
  • Biomarker Discovery

Background:

  • Pelviureteral junction obstruction is a common cause of kidney damage in children.
  • Accurate diagnosis and monitoring are crucial for preserving renal function.
  • Noninvasive diagnostic tools are highly desirable for pediatric patients.

Purpose of the Study:

  • To investigate the utility of transforming growth factor-beta1 (TGF-beta1) as a diagnostic marker for pediatric pelviureteral junction obstruction.
  • To assess the changes in urinary TGF-beta1 levels following surgical correction of the obstruction.

Main Methods:

  • Urinary TGF-beta1 levels were measured in children with confirmed pelviureteral junction obstruction and in a control group.
  • Samples included renal pelvic and bladder urine.
  • Bladder urine TGF-beta1 was re-evaluated 3 months after surgical intervention.

Main Results:

  • Renal pelvic urine TGF-beta1 was significantly higher than bladder urine in obstructed kidneys.
  • Bladder urine TGF-beta1 was significantly elevated in children with obstruction compared to controls.
  • A trend towards decreased bladder urine TGF-beta1 was observed post-surgery, though not statistically significant.
  • Urinary TGF-beta1 demonstrated 80% sensitivity, 82% specificity, and 81% accuracy for diagnosing obstruction.

Conclusions:

  • Urinary TGF-beta1 serves as a valuable noninvasive biomarker for diagnosing upper urinary tract obstruction in children.
  • Post-surgical follow-up shows a potential decrease in TGF-beta1 levels, suggesting its role in monitoring treatment response.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Imaging Studies V: Intravenous Urography and Retrograde Pyelography01:22

Imaging Studies V: Intravenous Urography and Retrograde Pyelography

IntroductionIntravenous Urography (IVU) and Retrograde Pyelography (RP) are important diagnostic imaging techniques used to evaluate the urinary system. These methods help identify structural abnormalities, obstructions, and functional issues in the kidneys, ureters, and bladder. Both procedures use iodine-based contrast media to enhance the visibility of urinary tract structures on X-ray images, though they differ in their methods and indications.1. Intravenous Urography (IVU)Intravenous...